Ian Judson


Ontology type: schema:Person     


Person Info

NAME

Ian

SURNAME

Judson

Publications in SciGraph latest 50 shown

  • 2018-12 Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response in CLINICAL SARCOMA RESEARCH
  • 2018-11 Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-10 Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma in MEDICAL ONCOLOGY
  • 2018-06 Correction: Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study in BRITISH JOURNAL OF CANCER
  • 2017-12 Radiation induced angiosarcoma of the breast: outcomes from a retrospective case series in CLINICAL SARCOMA RESEARCH
  • 2017-12 UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST) in CLINICAL SARCOMA RESEARCH
  • 2017-07-25 Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study in BRITISH JOURNAL OF CANCER
  • 2017-02 The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities in BRITISH JOURNAL OF CANCER
  • 2016-12 UK guidelines for the management of soft tissue sarcomas in CLINICAL SARCOMA RESEARCH
  • 2016-12 UK guidelines for the management of bone sarcomas in CLINICAL SARCOMA RESEARCH
  • 2016-10 Gene expression profiling identifies distinct molecular subgroups of leiomyosarcoma with clinical relevance in BRITISH JOURNAL OF CANCER
  • 2016-09 Olaratumab — really a breakthrough for soft-tissue sarcomas? in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2016-02 Phase I trial outcomes in older patients with advanced solid tumours in BRITISH JOURNAL OF CANCER
  • 2015-12 Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital in CLINICAL SARCOMA RESEARCH
  • 2015-12 A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma in CLINICAL SARCOMA RESEARCH
  • 2015-12 Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience in CLINICAL SARCOMA RESEARCH
  • 2015-12 First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma in CLINICAL SARCOMA RESEARCH
  • 2014-12 Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program in CLINICAL SARCOMA RESEARCH
  • 2014-12 Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience in CLINICAL SARCOMA RESEARCH
  • 2014-12 Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors in CLINICAL SARCOMA RESEARCH
  • 2014-10 Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit in GASTRIC CANCER
  • 2014-07 Dichloroacetate induces autophagy in colorectal cancer cells and tumours in BRITISH JOURNAL OF CANCER
  • 2014-04 Systemic treatment of soft-tissue sarcoma—gold standard and novel therapies in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2014-03 Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era? in LANGENBECK'S ARCHIVES OF SURGERY
  • 2013-12 Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis in CLINICAL SARCOMA RESEARCH
  • 2013-12 Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature in CLINICAL SARCOMA RESEARCH
  • 2013-10 Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials in BRITISH JOURNAL OF CANCER
  • 2013-09 Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumours in BRITISH JOURNAL OF CANCER
  • 2012-07 Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging in EUROPEAN RADIOLOGY
  • 2012-06 A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-04 Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2012-02 A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma in INVESTIGATIONAL NEW DRUGS
  • 2012-01 The safety profile of imatinib in CML and GIST: long-term considerations in ARCHIVES OF TOXICOLOGY
  • 2012 Clinical Presentation of Desmoid Tumors in DESMOID TUMORS
  • 2011-12 A patient presenting with a perivascular epithelioid cell tumor in the broad ligament: a case report in JOURNAL OF MEDICAL CASE REPORTS
  • 2011-12 Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case report in JOURNAL OF MEDICAL CASE REPORTS
  • 2011-09 Chemotherapy in clear cell sarcoma in MEDICAL ONCOLOGY
  • 2011-08 Clinical benefit of early phase clinical trial participation for advanced sarcoma patients in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2011-06 Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial in INVESTIGATIONAL NEW DRUGS
  • 2011-05 Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study in BRITISH JOURNAL OF CANCER
  • 2010-05 A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva®, OSI-774) in patients with advanced solid tumors of epithelial origin in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2009-12 A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy in BRITISH JOURNAL OF CANCER
  • 2009-11 Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial in EUROPEAN RADIOLOGY
  • 2009-05 Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter? in BRITISH JOURNAL OF CANCER
  • 2008-12 Late widespread skeletal metastases from myxoid liposarcoma detected by MRI only in WORLD JOURNAL OF SURGICAL ONCOLOGY
  • 2008-10 Reply: Clinical outcome and prognostic factors for patients treated within a phase I study: the Royal Marsden Hospital Experience in BRITISH JOURNAL OF CANCER
  • 2008-10 An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2008-03 Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience in BRITISH JOURNAL OF CANCER
  • 2007-01 A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days in BRITISH JOURNAL OF CANCER
  • 2006-05 Phase I study of Vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks in INVESTIGATIONAL NEW DRUGS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.5072.0", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10419.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.8756.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419481.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.439338.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4991.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.482245.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.154185.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.476460.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.24827.3b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5252.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.11835.3e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410569.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417079.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.443984.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411083.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415490.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416353.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418116.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.18886.3f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413696.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.8515.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5645.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415720.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.11485.39", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.424926.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415193.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9654.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411599.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418936.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418596.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419513.b", 
            "type": "Organization"
          }
        ], 
        "familyName": "Judson", 
        "givenName": "Ian", 
        "id": "sg:person.01132707630.61", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
            "0000-0002-4766-5304"
          ]
        }, 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132707630.61", 
          "https://orcid.org/0000-0002-4766-5304"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:14", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_908.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01132707630.61'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01132707630.61'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01132707630.61'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01132707630.61'


     

    This table displays all metadata directly associated to this object as RDF triples.

    89 TRIPLES      11 PREDICATES      47 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01132707630.61 schema:affiliation N375ef28fe12a4c5eb117c197c4185335
    2 https://www.grid.ac/institutes/grid.10419.3d
    3 https://www.grid.ac/institutes/grid.11485.39
    4 https://www.grid.ac/institutes/grid.11835.3e
    5 https://www.grid.ac/institutes/grid.14925.3b
    6 https://www.grid.ac/institutes/grid.154185.c
    7 https://www.grid.ac/institutes/grid.18886.3f
    8 https://www.grid.ac/institutes/grid.240145.6
    9 https://www.grid.ac/institutes/grid.24827.3b
    10 https://www.grid.ac/institutes/grid.410569.f
    11 https://www.grid.ac/institutes/grid.411083.f
    12 https://www.grid.ac/institutes/grid.411599.1
    13 https://www.grid.ac/institutes/grid.413696.f
    14 https://www.grid.ac/institutes/grid.415193.b
    15 https://www.grid.ac/institutes/grid.415490.d
    16 https://www.grid.ac/institutes/grid.415720.5
    17 https://www.grid.ac/institutes/grid.416353.6
    18 https://www.grid.ac/institutes/grid.417079.c
    19 https://www.grid.ac/institutes/grid.417893.0
    20 https://www.grid.ac/institutes/grid.418116.b
    21 https://www.grid.ac/institutes/grid.418596.7
    22 https://www.grid.ac/institutes/grid.418936.1
    23 https://www.grid.ac/institutes/grid.419481.1
    24 https://www.grid.ac/institutes/grid.419513.b
    25 https://www.grid.ac/institutes/grid.424926.f
    26 https://www.grid.ac/institutes/grid.439338.6
    27 https://www.grid.ac/institutes/grid.443984.6
    28 https://www.grid.ac/institutes/grid.476460.7
    29 https://www.grid.ac/institutes/grid.482245.d
    30 https://www.grid.ac/institutes/grid.4991.5
    31 https://www.grid.ac/institutes/grid.5252.0
    32 https://www.grid.ac/institutes/grid.5645.2
    33 https://www.grid.ac/institutes/grid.8515.9
    34 https://www.grid.ac/institutes/grid.8756.c
    35 https://www.grid.ac/institutes/grid.9654.e
    36 schema:familyName Judson
    37 schema:givenName Ian
    38 schema:identifier Nf9abd1e6511f47ac826aa3d5e7c29cca
    39 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132707630.61
    40 https://orcid.org/0000-0002-4766-5304
    41 schema:sdDatePublished 2019-03-07T15:14
    42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    43 schema:sdPublisher Nf68d4a59127d4b0c9a8c0f53d5d243f9
    44 sgo:license sg:explorer/license/
    45 sgo:sdDataset persons
    46 rdf:type schema:Person
    47 N375ef28fe12a4c5eb117c197c4185335 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
    48 sgo:isCurrent true
    49 rdf:type schema:OrganizationRole
    50 Nf68d4a59127d4b0c9a8c0f53d5d243f9 schema:name Springer Nature - SN SciGraph project
    51 rdf:type schema:Organization
    52 Nf9abd1e6511f47ac826aa3d5e7c29cca schema:name orcid_id
    53 schema:value 0000-0002-4766-5304
    54 rdf:type schema:PropertyValue
    55 https://www.grid.ac/institutes/grid.10419.3d schema:Organization
    56 https://www.grid.ac/institutes/grid.11485.39 schema:Organization
    57 https://www.grid.ac/institutes/grid.11835.3e schema:Organization
    58 https://www.grid.ac/institutes/grid.14925.3b schema:Organization
    59 https://www.grid.ac/institutes/grid.154185.c schema:Organization
    60 https://www.grid.ac/institutes/grid.18886.3f schema:Organization
    61 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    62 https://www.grid.ac/institutes/grid.24827.3b schema:Organization
    63 https://www.grid.ac/institutes/grid.410569.f schema:Organization
    64 https://www.grid.ac/institutes/grid.411083.f schema:Organization
    65 https://www.grid.ac/institutes/grid.411599.1 schema:Organization
    66 https://www.grid.ac/institutes/grid.413696.f schema:Organization
    67 https://www.grid.ac/institutes/grid.415193.b schema:Organization
    68 https://www.grid.ac/institutes/grid.415490.d schema:Organization
    69 https://www.grid.ac/institutes/grid.415720.5 schema:Organization
    70 https://www.grid.ac/institutes/grid.416353.6 schema:Organization
    71 https://www.grid.ac/institutes/grid.417079.c schema:Organization
    72 https://www.grid.ac/institutes/grid.417893.0 schema:Organization
    73 https://www.grid.ac/institutes/grid.418116.b schema:Organization
    74 https://www.grid.ac/institutes/grid.418596.7 schema:Organization
    75 https://www.grid.ac/institutes/grid.418936.1 schema:Organization
    76 https://www.grid.ac/institutes/grid.419481.1 schema:Organization
    77 https://www.grid.ac/institutes/grid.419513.b schema:Organization
    78 https://www.grid.ac/institutes/grid.424926.f schema:Organization
    79 https://www.grid.ac/institutes/grid.439338.6 schema:Organization
    80 https://www.grid.ac/institutes/grid.443984.6 schema:Organization
    81 https://www.grid.ac/institutes/grid.476460.7 schema:Organization
    82 https://www.grid.ac/institutes/grid.482245.d schema:Organization
    83 https://www.grid.ac/institutes/grid.4991.5 schema:Organization
    84 https://www.grid.ac/institutes/grid.5072.0 schema:Organization
    85 https://www.grid.ac/institutes/grid.5252.0 schema:Organization
    86 https://www.grid.ac/institutes/grid.5645.2 schema:Organization
    87 https://www.grid.ac/institutes/grid.8515.9 schema:Organization
    88 https://www.grid.ac/institutes/grid.8756.c schema:Organization
    89 https://www.grid.ac/institutes/grid.9654.e schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...